Leef Brands (LEEEF) Short term Debt (2024 - 2026)
Leef Brands' (LEEEF) quarterly Short term Debt came in at $105000.0 in Q1 2026, down 69.12% quarter-over-quarter from $340000.0 in Q4 2025.
Leef Brands (LEEEF) Short term Debt (2024 - 2026) Analysis & Trends
Leef Brands has disclosed Short term Debt across 3 years of filings, most recently posting $105000.0 for Q1 2026.
- Short term Debt for Q1 2026 came in at $105000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $105000.0 (changed N/A YoY), and the FY2025 annual result was $340000.0, down 32.0% from the prior year.
- Short term Debt came in at $105000.0 for Q1 2026 at Leef Brands, down from $340000.0 in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $500000.0 in Q4 2024 to a low of $105000.0 in Q1 2026.
- The 3-year median for Short term Debt is $340000.0 (2025), against an average of $315000.0.
- Peak annual rise in Short term Debt reached 32.0% in 2025, while the deepest fall reached 32.0% in 2025.
- Leef Brands' Short term Debt stood at $500000.0 in 2024, then slumped by 32.0% to $340000.0 in 2025, then tumbled by 69.12% to $105000.0 in 2026.
- The last three Short term Debt figures came in at $105000.0 (Q1 2026), $340000.0 (Q4 2025), and $500000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Leef Brands | - | - | 4.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 105,000.00 |
| Dec 31, 2025 | 340,000.00 |
| Dec 31, 2024 | 500,000.00 |